News

Investigators studied apixaban pharmacokinetics, pharmacodynamics, and hemorrhage risk by kidney function. Kidney function is a major predictor of hemorrhage among patients with atrial fibrillation ...
A recent study published in JAMA has found that certain blood pressure medications may raise the risk of serious bleeding in ...
People with type 2 diabetes who used semaglutide (Ozempic) versus other drugs had a lower risk of Alzheimer's disease and ...
Researchers sought to determine whether a reduced dose of apixaban would be as effective as using full-dose apixaban in preventing recurrent VTE in patients with active cancer.
We conducted the Apixaban Cancer Associated Thrombosis (API-CAT) trial to assess whether a reduced-dose regimen of apixaban (2.5 mg twice daily) would be noninferior to a full-dose regimen (5.0 mg ...
CHICAGO — For patients with cancer requiring extended anticoagulant therapy, a strategy of reduced-dose apixaban was noninferior to full-dose apixaban for prevention of cancer-associated ...
Bristol-Myers Squibb provided the apixaban free of charge. It was an investigator- sponsored study coordinated by Assistance Publique des Hôpitaux de Paris (AP-HP).
For people with HIV and atrial fibrillation (Afib or AF), certain oral anticoagulants (OACs) may carry a higher bleeding risk than others, according to a study based on Medicare records. From a ...
Heightened interest in left ventricular thrombus (LVT) stems from the consistent association of subsequent stroke and ...
Medically reviewed by Jeffrey S. Lander, MD There are many types and combinations of drugs used to treat a myocardial infarction (MI), also known as a heart attack. These drugs can help prevent blood ...
News Release 31-Oct-2024 Apixaban vs aspirin in patients with cancer and cryptogenic stroke Peer-Reviewed Publication Ochsner Health System ...
Apixaban is a generic oral tablet that’s prescribed for certain types of blood clots. It’s available as the brand-name drug Eliquis. The cost of apixaban, with and without insurance, can ...